ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 3.680
-0.060 (-1.60%)
At close: Jan 9, 2026
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €59.3 million as of January 12, 2026. Its market cap has increased by 49.59% in one year.
Market Cap
59.30M
Enterprise Value
61.06M
Revenue
6.23M
Ranking
n/a
PE Ratio
127.98
Stock Price
€3.68
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 59.30M, an increase of 2,264.31%. That is a compound annual growth rate of 13.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 59.30M | 22.67% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 128.15B |
| Sanofi | 102.75B |
| Sartorius Stedim Biotech | 20.85B |
| bioMérieux | 13.33B |
| Eurofins Scientific SE | 12.24B |
| Ipsen | 10.46B |
| ABIVAX Société Anonyme | 7.71B |
| Virbac | 3.05B |